Deep Blue Observer Maritime Domain Awareness Joint Challenge
Inviting global companies, startups, and academia to address challenges in the areas of maritime security.
All submissions will be assessed by a panel comprising members from the Organisers, and based on the following criteria:
Innovativeness and Relevance
- How innovative is the solution?
- Can the solution address the challenge statements effectively?
Tech Feasibility and Readiness for Implementation
- How easy is the solution able to scale for large-scale deployment in a cost-effective manner?
- Has the solution been adopted commercially?
Open for Applications
Applications are open from 11 - 25 September 2026, Friday, 11:59hrs (SGT/GMT+8) / 24 September 2026, Thursday, 23:59 (ET)
To apply:
- Register an account on the platform.
- Select a challenge and statement to address.
- Download and review the Conditions of Contract (CoC).
- Complete the CoC annex proposal template and upload the completed proposal in .pdf format, along with supporting documents to complete your submission.
- How innovative and relevant is the solution to address the challenge statements.
- How feasible is your tech solution for implementation.
- How easy is the solution able to scale for large-scale deployment in a cost-effective manner.
- Examples where the solution has been adopted commercially, if applicable.
You may also refer to the Frequently Asked Questions (FAQ) for more details.
Evaluation & Shortlisting of Proposals
September - November 2026
We will invite shortlisted providers to a pitching session to present their proposals and address any queries from our evaluation panel.
Pitching Session
4 December 2026 (GMT+8) - Hybrid
During the pitching session, participants will be provided the opportunity to elaborate on their solutions and clarify any queries from the evaluation panel.
Successful participants may be awarded a contract by Cap Vista or the U.S. War Innovation Unit, or both to demonstrate their technology in a short trial.
We aim to scale the solution quickly if the trial demonstrates success and good potential.